Clinical phenotype of Alport syndrome in monozygotic twins

Objective: To analyze the consistency of the clinical phenotype of Alport syndrome between monozygotic twins. Methods: This retrospective study included identical twins with Alport syndrome who met the inclusion and exclusion criteria and were admitted to Peking University First Hospital from Januar...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 58(2020), 9 vom: 02. Sept., Seite 731-737
1. Verfasser: Deng, H Y (VerfasserIn)
Weitere Verfasser: Wang, F, Zhang, Y Q, Zhu, R L, Ding, J
Format: Online-Aufsatz
Sprache:Chinese
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:Journal Article Twin Study Alport syndrome Monozygotic twins Phenotype X-linked genetic disease
LEADER 01000naa a22002652 4500
001 NLM314457100
003 DE-627
005 20231225152756.0
007 cr uuu---uuuuu
008 231225s2020 xx |||||o 00| ||chi c
024 7 |a 10.3760/cma.j.cn112140-20200701-00679  |2 doi 
028 5 2 |a pubmed24n1048.xml 
035 |a (DE-627)NLM314457100 
035 |a (NLM)32872713 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Deng, H Y  |e verfasserin  |4 aut 
245 1 0 |a Clinical phenotype of Alport syndrome in monozygotic twins 
264 1 |c 2020 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 04.12.2020 
500 |a Date Revised 14.12.2020 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Objective: To analyze the consistency of the clinical phenotype of Alport syndrome between monozygotic twins. Methods: This retrospective study included identical twins with Alport syndrome who met the inclusion and exclusion criteria and were admitted to Peking University First Hospital from January 2000 to March 2019. Their clinical data and urinary epidermal growth factor (uEGF) level were extracted from the on-line registry system of hereditary kidney diseases, and analyzed retrospectively. Results: Three pairs of monozygotic twins with X-linked Alport syndrome from three non-consanguineous families were included. The consistency of the genotype status between the twins tended to confirm their monozygotic relationship. The first twins were term infants, and the twin 1A had a normal birth weight (2 500 g) while twin 1B was small for gestational age (2 450 g) . The other two pairs of twins were preterm, with different birth weights between twins 2 (2A is 2 450 g, 2B is 1 900 g) , but similar birth weights between twins 3. Although raised in the same environment, compared with twin 1A, 1B had obvious growth retardation. However, growth rate in the remaining twins were consistent. The renal abnormalities were not exactly the same between both twins 1 and twins 2, but was almost the same in twins 3. Both 1A and 1B were characterized by massive proteinuria and renal dysfunction, whereas 1B had worse renal function. At the last follow-up, 1A was diagnosed with stage 3 of chronic kidney disease (CKD) whereas 1B was CKD stage 4. Although renal function in twins 2 were normal, 2A had prominent proteinuria(24 h urinary total protein: 0.22 g) while 2B only had microalbuminuria(urinary albumin-to-creatinine ratio: 65 mg/g). Compared with the age-matched healthy controls, the concentration of uEGF normalized by urine creatinine (uEGF/Cr) were significantly lower in these twins. Besides, the twin-boy who had lower estimated glomerular filtration rates had lower uEGF/Cr. However, the extrarenal manifestations such as ocular and acoustic abnormalities were similar between the twins. Twins 2 and 3 showed bilateral temporal retinal thinning, and twins 1 both had binaural mild mid-low frequency sensorineural deafness. Conclusions: Renal manifestations of X-linked Alport syndrome in monozygotic twins may differ from each other, whereas the extrarenal manifestations including ocular and acoustic abnormalities may be consistent. Low birth weight and growth retardation may be associated with the progression of renal dysfunction 
650 4 |a Journal Article 
650 4 |a Twin Study 
650 4 |a Alport syndrome 
650 4 |a Monozygotic twins 
650 4 |a Phenotype 
650 4 |a X-linked genetic disease 
700 1 |a Wang, F  |e verfasserin  |4 aut 
700 1 |a Zhang, Y Q  |e verfasserin  |4 aut 
700 1 |a Zhu, R L  |e verfasserin  |4 aut 
700 1 |a Ding, J  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 58(2020), 9 vom: 02. Sept., Seite 731-737  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnns 
773 1 8 |g volume:58  |g year:2020  |g number:9  |g day:02  |g month:09  |g pages:731-737 
856 4 0 |u http://dx.doi.org/10.3760/cma.j.cn112140-20200701-00679  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 58  |j 2020  |e 9  |b 02  |c 09  |h 731-737